MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

SCHEDULE OF SERIES B PREFERRED STOCK

The following table illustrates the activity of the Series B Preferred Stock during the year ended December 31, 2024:

Balance as of December 31, 2023	$	-
Issuance of 422,200 Series B Preferred Stock due to Offering		1,568,895
Accretion of 422,200 Series B Preferred Stock due to Offering		4,168,752
Issuance of 100,592 Series B Preferred Stock due to exchange		1,307,696
Accretion of 100,592 Series B issuances		52,088
Issuance of 5,000 Series B Preferred Stock due to extension		15,000
Series B Preferred Stock conversion of liability		50,000
Accretion of 5,000 Series B issuances		3,602
Issuance of 50,453 Series B Preferred Stock		655,889
Accretion of 50,453 Series B issuances		25,157
Balance as of December 31, 2024	$	7,847,079

SCHEDULE OF CHANGES IN COMMON STOCK WARRANTS

						Weighted				Weighted
	Warrants Outstanding					Average				Average
	Number			Exercise		Remaining		Aggregate		Exercise
	Of			Price		Contractual		Intrinsic		Price
	Shares			Per Share		Life		Value		Per Share
Balance at December 31, 2022		-		$	-		-	$	-	$	-
Warrants acquired concurrent with the Titan Merger		108,734			$ 0.008 – 16.00		0.37	$	24,905	$	9.29
Warrants granted		2,500,000		$	0.06		5.00	$	1,600,000	$	0.06
Warrants exercised		-		$	-		-	$	-	$	-
Warrants expired/cancelled		-		$	-		-	$	-	$	-
Balance at December 31, 2023		2,608,734			$ 0.008 – 16.00		4.81	$	1,624,905	$	0.44
Exercisable at December 31, 2023		2,606,907			$ 0.008 – 16.00		4.81	$	1,623,641	$	0.45
Warrants granted		94,699,839		$	0.06		4.58	$	22,355,963	$	9.29
Warrants exercised/exchanged		-		$	-		-	$	-	$	0.06
Warrants expired/cancelled		(98,803	)		$ 0.008 – 16.00		-	$	-	$	-
Balance at December 31, 2024		97,209,770			$ 0.06 – 11.60		4.56	$	22,355,963	$	0.06
Exercisable at December 31, 2024		97,209,770			$ 0.06 – 11.60		4.56	$	22,355,963	$	0.06